An essential step in preclinical drug development is confirming the specific binding of the novel…
By Jordi Casals, president, EMEA, Amryt Pharma Epidermolysis bullosa (EB), sometimes described as “the worst…
By Shawn Gaskell, MilliporeSigma RSV-related hospitalizations for 2022 have already surged to unusually high numbers,…
By Bob Coughlin, managing director, life sciences, JLL For the last two years, the pandemic…
More academic groups, new start-ups, biotechs and small pharma companies are turning to external consultants…
Precision medicine research relies on genetic testing at scale, but how do we reach more…
Guy Levy-Yurista, CEO of the experiment platform developer Synthace, gives his take on what’s missing…
Neil Ward, general manager of PacBio EMEA With applications of CRISPR across the spectrum of…
A Q&A with Fady Riad, CEO of consulting company Centurion Life Sciences. How did CRISPR/Cas9…
Next-generation proteomics has a vital role to play in the search for new biomarkers of…
Following its successful MedTech competition earlier this year, the UK’s largest kidney research charity, Kidney…
With increasingly complex therapeutics arriving almost monthly, efficient technology transfer between biopharma and manufacturers is…
